Navigation Links
SafeCode Drug Technologies to Hire Project Manager to Market FDA Approved Painless Injection Device
Date:4/17/2013

JERUSALEM, April 17, 2013 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of technologies that reduces errors and eliminates pain during the administration of prescription medications, announced today that the company intends to hire a Project Manager to oversee and implement a marketing strategy to commercialize its newly acquired painless injection device.

The company's new technology is fully approved by the Federal Drug Administration (FDA), and has demonstrated itself to be safe and effective in actively reducing pain during the administration of blood tests, lanching and injections - a daily reality for many during ongoing medical care.

Both EZJect and Quickool - the newly acquired technologies - received FDA approval for commercialization in 2007.

"To acquire technology that already has FDA approval, is a major step toward full commercialization in the United States," said Akiva Schonfled, Chief Executive Officer of SafeCode Drug Technologies.  "These technologies have applications in hospitals, doctor's offices and clinics, in addition to the at-home, individual care markets. We are confident that with the right project manager in place, we can implement a winning commercialization strategy."

About SafeCode Drug Technologies

SafeCode Drug Technologies is the developer of patent-pending technologies that reduce errors and eliminate pain during the administration of prescription medications. The company's initial technology is voice-activated administration technology that ensures the proper medication is administered to the proper patient. The company's newly acquired EZJect technology eliminates pain during blood tests and injections.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact:
CEO, Akiva Schonfled
+9722-582-0394


'/>"/>
SOURCE Safecode Drug Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SafeCode Drug Technologies Initiating Activities to Commercialize its Recent Newly Acquired Technology of the Pain-Free Injection
2. SafeCode Drug Technologies Acquires Breakthrough Painless Injection Technology
3. SafeCode Drug Technologies Corp Signs an Agreement With INTOVISION PRODUCT DEVELOPMENT & DESIGN (An Israeli Product Development Co) to Manufacturers the Worlds First Voice Recognition Drug Safety Application Prototype
4. SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the Worlds First Prototype for its Next Generation Application for Drug Safety Administration
5. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
6. SafeCode Drug Technologies Corp. in Negotiations With Manufacturers to Develop Prototype
7. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
8. Antibody Technologies and Attrition Rates - An Industry Analysis 2013
9. Remedium Technologies Inc. Awarded $500,000 Phase II NSF SBIR Grant to Test Sprayable Foam for Stopping Traumatic Bleeding
10. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
11. Multisorb Technologies Non-Toxic StabilOx Oxygen Absorbing Canisters Provide Worry-Free Drug Stability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):